GlassScriptPhysician profile
Amanda Rose Gartner
NPI 1821757311
$5,245.05
in general payments reported to CMS, 2019-2025
27 companies · $1,159 in 2025
The $1,159 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $272 · 2023: $2,166 · 2024: $1,648 · 2025: $1,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,874 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,873.92 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,077.82 | 2023-2025 | Repatha, Repatha |
| Inari Medical, INC. | $648.92 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $431.48 | 2023-2025 | Watchman Flx, Bodyguardian, Cds - Mct/Cem Monitoring |
| Janssen Pharmaceuticals, INC | $406.40 | 2022-2024 | Xarelto |
| Abiomed | $335.87 | 2023-2025 | Impella |
| Novo Nordisk INC | $308.20 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $292.18 | 2023-2024 | |
| Edwards Lifesciences Corporation | $290.63 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Atricure, INC. | $237.47 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Actelion Pharmaceuticals US, INC. | $231.26 | 2023 | Uptravi, Opsumit |
| Inspire Medical Systems, INC. | $190.51 | 2024-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $156.66 | 2022-2024 | Farxiga |
| Pfizer INC. | $99.23 | 2024-2025 | |
| Heartflow, INC. | $97.10 | 2023-2025 | Ffrct |
| Agepha Pharma Fz LLC | $73.50 | 2024 | Lodoco |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $70.40 | 2023 | Verquvo |
| Alnylam Pharmaceuticals INC. | $50.75 | 2023-2024 | Onpattro |
| Sanofi-Aventis U.S. LLC | $37.10 | 2024 | |
| Baxter Healthcare | $34.48 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $34.26 | 2024-2025 | Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.84 | 2023 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $22.16 | 2022 | |
| Glaxosmithkline, LLC. | $20.65 | 2025 | Arexvy, Shingrix |
| Penumbra, INC. | $20.36 | 2024 | Indigo System |
| Daiichi Sankyo INC. | $20.00 | 2023 | Injectafer |
| Medtronic, INC. | $17.80 | 2023 | Intellis Adaptivestim |
| G Medical Diagnostic Services, INC. | $13.02 | 2023 | Cardiac Monitoring Suite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Gartner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.